| Dr Stephen M Maloff, MD | |
|
2240 E Center St, Pocatello, ID 83201 | |
| (208) 233-8344 | |
| (208) 233-6983 |
| Full Name | Dr Stephen M Maloff |
|---|---|
| Gender | Male |
| Speciality | Plastic And Reconstructive Surgery |
| Experience | 57 Years |
| Location | 2240 E Center St, Pocatello, Idaho |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316059280 | NPI | - | NPPES |
| 76814 | Other | ID | BLUE CROSS OF ID |
| 000010024275 | Other | ID | REGENCE BLUE SHIELD OF ID |
| 242157007 | Other | ID | RAILROAD MEDICARE |
| 003833100 | Medicaid | ID |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2082S0099X | Plastic Surgery - Plastic Surgery Within The Head And Neck | M3508 (Idaho) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Bmh Inc | 8426149758 | 124 |
News Archive
Although laparoscopic radical cystectomy (LRC) and robotic assisted radical cystectomy (RARC) continue to grow in popularity and are successful in the treatment of bladder cancer, they are still considered experimental approaches. Using data collected by the Section of Uro-Technology of the European Association of Urology (ESUT), a team of researchers found that about 5% of patients experienced unexpected relapses of cancer after LRC, even with favorable pathology.
Scientists at the Walter Reed Army Institute for Research have recently demonstrated that cathepsin B, a well-studied protein important to brain development and function, can be used as biomarker, or indicator of severity, for traumatic brain injury.
ImaCor Inc., the developer of the world's only hemodynamic transesophageal echocardiography technology, announced that multiple recent studies have shown that hTEE significantly changes patient management in critical care.
Companies involved in the life science tools market must consider a multitude of technologies, economic drivers and societal trends in developing strategies for the future.
› Verified 5 days ago
| Entity Name | Bmh Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255539193 PECOS PAC ID: 8426149758 Enrollment ID: O20071018000897 |
News Archive
Although laparoscopic radical cystectomy (LRC) and robotic assisted radical cystectomy (RARC) continue to grow in popularity and are successful in the treatment of bladder cancer, they are still considered experimental approaches. Using data collected by the Section of Uro-Technology of the European Association of Urology (ESUT), a team of researchers found that about 5% of patients experienced unexpected relapses of cancer after LRC, even with favorable pathology.
Scientists at the Walter Reed Army Institute for Research have recently demonstrated that cathepsin B, a well-studied protein important to brain development and function, can be used as biomarker, or indicator of severity, for traumatic brain injury.
ImaCor Inc., the developer of the world's only hemodynamic transesophageal echocardiography technology, announced that multiple recent studies have shown that hTEE significantly changes patient management in critical care.
Companies involved in the life science tools market must consider a multitude of technologies, economic drivers and societal trends in developing strategies for the future.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Stephen M Maloff, MD 2240 E Center St, Pocatello, ID 83201 Ph: (208) 233-8344 | Dr Stephen M Maloff, MD 2240 E Center St, Pocatello, ID 83201 Ph: (208) 233-8344 |
News Archive
Although laparoscopic radical cystectomy (LRC) and robotic assisted radical cystectomy (RARC) continue to grow in popularity and are successful in the treatment of bladder cancer, they are still considered experimental approaches. Using data collected by the Section of Uro-Technology of the European Association of Urology (ESUT), a team of researchers found that about 5% of patients experienced unexpected relapses of cancer after LRC, even with favorable pathology.
Scientists at the Walter Reed Army Institute for Research have recently demonstrated that cathepsin B, a well-studied protein important to brain development and function, can be used as biomarker, or indicator of severity, for traumatic brain injury.
ImaCor Inc., the developer of the world's only hemodynamic transesophageal echocardiography technology, announced that multiple recent studies have shown that hTEE significantly changes patient management in critical care.
Companies involved in the life science tools market must consider a multitude of technologies, economic drivers and societal trends in developing strategies for the future.
› Verified 5 days ago
Dr. Silas Angier Wills Jr., MD Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 1950 E Clark St, Ste A, Pocatello, ID 83201 Phone: 208-232-5550 Fax: 208-232-5553 |